Bob Bradway, Chairman and CEO at Amgen, shared on LinkedIn:
“It was a pleasure to welcome leaders from around the world who advocate on behalf of patients and their communities to Amgen for our 2026 Advocacy Summit.
I appreciated the opportunity to hear directly from them about the communities they serve and the challenges patients continue to face.
Their perspectives are important to our work and to how we think about serving patients.
Thank you to everyone who joined us for the candid conversations, insights and continued partnership.
By listening to and learning from one another, we can make a meaningful difference for patients around the world.”
Other articles about Amgen on OncoDaily.